Prevention of Cancer Development and Progression

Status:
Not yet recruiting

Trial end date:
2025-05-10

Target enrollment:

Participant gender:

The purpose of this study is to evaluate the efficacy and safety of arginine in preventing cancer development

Phase 3

Zujiang YU